PTEN Research funds research that will lead to new and better treatments for PHTS.
We are the only UK-based global medical research charity that is dedicated to developing targeted therapies to treat PHTS. Our goal is to improve the quality of life of those affected by PHTS by providing new and better treatment options, and by creating an evidence base from which to develop better care and management.
We globally fund research with academic, clinical and industry partners.
Below are the main areas of research that PTEN Research supports. For more information on our scientific strategy, click here.
We are focusing on the assessment of the rapalog drug class to develop treatment options for specific symptoms of PHTS which may bring meaningful benefit to patients.
We provide grants through three mechanisms:
We fund research projects that can translate into better treatments for PHTS patients. This includes clinical research studies, interventional clinical trials, preclinical/translational research projects and, where appropriate, basic research projects.
Funding is intended to support all essential direct costs relating to the project, including staffing, consumables, equipment, travel and publication costs.
Eligibility to apply for funding is not restricted to any specific geography.
In general, PTEN Research awards grants to Principal Investigators who have qualified with an MD or PhD and have an established research programme in a recognised academic or clinical research institution. Seed funding may be awarded to sufficiently qualified researchers currently associated with an academic or clinical research institution.
Non-academic entities may also be eligible to apply for grant funding depending on the grant call.
For any further clarification or questions relating to our eligibility criteria, please contact firstname.lastname@example.org.
Applications should be made in line with requirements detailed for the specific call. There are currently no open targeted calls accepting applications. Targeted calls will be announced on our website, social media and other appropriate platforms. To keep up to date on our targeted call opportunities consider signing up to our newsletter.
PTEN Research will acknowledge the submission of application within a week of receipt. All applications will be checked for completion. If an application does not meet the mandatory eligibility criteria, as specified by the targeted call, it will not be processed and will be returned to the applicant.
All applications will undergo scientific, budgetary and programmatic assessment by our scientific research team followed by external peer review by a minimum of two independent experts. Applicants will be provided with feedback on their application and will have an opportunity to respond to any specific questions raised.
All applications are assessed by our Scientific Advisory Board before the final funding decision is made by our Trustee Board.
For any more information about applications please contact email@example.com.